Cryo-Cell International Inc.
NYSE
Real-time Data
01:30 PM
Day's Range
3.3552 wk Range
2.72Key Statistics
Symbol
CCEL
Name
Cryo-Cell International Inc.
Currency
USD
Exchange
NYSE
High
3.35
Low
3.35
Open
‪3.35‬
Last
‪3.35‬
Market Cap
27.89M
Pe Ratio
‪475.00‬
Volume
8
Average Volume
6.42K
Dividend Yield
‪4.29%‬
Change
-0.11
Percent Change
-3.18
Timestamp
2026-07-20
Close
3.35
Today Range Start
‪3.35‬
Today Range End
‪3.35‬
52 Week Range Start
‪2.72‬
52 Week Range End
‪5.43‬
Type
Stocks
Country
United States
Compliance - CCEL - Cryo-Cell International Inc.
Compliance
Status
COMPLIANT
Report Date
2025-02-20
Business Screen
COMPLIANT
Financial Screen
COMPLIANT
Compliant Revenue
‪98.00%‬
Non Compliant Revenue
‪2.00%‬
Questionable Revenue
‪0.00%‬
Securities To Market Cap Ratio
‪10.00%‬
Debt To Market Cap Ratio
‪10.00%‬
Historical Data - CCEL - Cryo-Cell International Inc.
Historical Data
Market Cap - CCEL - Cryo-Cell International Inc.
Market Cap
2026-07-17
27.89M
2026-07-16
28.03M
2026-07-15
28.79M
2026-07-14
27.38M
2026-07-13
28.19M
2026-07-10
27.54M
2026-07-09
28.50M
2026-07-08
27.65M
2026-07-07
28.75M
2026-07-06
29.07M
Dividend - CCEL - Cryo-Cell International Inc.
Dividend
2025-05-21
0.1500
Earnings - CCEL - Cryo-Cell International Inc.
Earnings
Balance Sheet - CCEL - Cryo-Cell International Inc.
Balance Sheet
Cash Flow - CCEL - Cryo-Cell International Inc.
Cash Flow
Income Statement - CCEL - Cryo-Cell International Inc.
Income Statement
Recommendations - CCEL - Cryo-Cell International Inc.
Recommendations
Profile - CCEL - Cryo-Cell International Inc.
Profile
Mic Code
XASE
Sector
Healthcare
Industry
Medical Care Facilities
Employees
72
Cryo-Cell International Inc. is a prominent biotechnology company that specializes in cord blood and tissue banking services. Established with a focus on providing families with the opportunity to preserve vital biological resources, Cryo-Cell collects and stores umbilical cord blood and tissue at the time of a child's birth. These stored cells can potentially be used in future medical treatments due to their ability to differentiate into various cell types. The primary purpose of Cryo-Cell is to offer reliable and accessible solutions for parents wishing to safeguard their children's health against potential future illnesses, such as blood disorders and certain genetic diseases. Operating within the healthcare and biotech sectors, Cryo-Cell International Inc. plays a crucial role in the rapidly evolving field of regenerative medicine, contributing to advancements in cellular therapies and research. With its headquarters in Oldsmar, Florida, the company is a significant participant in the biotechnology industry, known for its emphasis on innovation, quality control, and adherence to rigorous industry standards. As a trusted entity in its domain, Cryo-Cell remains committed to expanding its scientific capabilities and enhancing the scope of its services, thereby impacting the broader medical and scientific communities.
Profile Details
Type
Common Stock
Address
700 Brooker Creek Boulevard
City
Oldsmar
State
FL
Zip
34677
Country
United States
Phone
813 749 2100
